43
Participants
Start Date
December 31, 2007
Primary Completion Date
February 28, 2011
Study Completion Date
February 28, 2011
PF-03732010
IV infusion. Escalating dose levels, starting at 0.5 mg/kg to Maximum Tolerated Dose. Cycle length of 4 weeks for first cycle, and 2 weekly for subsequently cycles was originally explored, yet based on emerging PK data the Cycle 1 duration is 2 weeks and then weekly. Number of Cycles: Until Progression or unacceptable toxicity develops.
Pfizer Investigational Site, Parkville
Pfizer Investigational Site, Philadelphia
Pfizer Investigational Site, Seoul
Lead Sponsor
Pfizer
INDUSTRY